375 related articles for article (PubMed ID: 31269966)
21. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
22. Cross-border collaboration for neglected tropical disease efforts-Lessons learned from onchocerciasis control and elimination in the Mano River Union (West Africa).
Gustavsen K; Sodahlon Y; Bush S
Global Health; 2016 Aug; 12(1):44. PubMed ID: 27549911
[TBL] [Abstract][Full Text] [Related]
23. Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Kelly-Hope LA; Sanders AM; Harding-Esch E; Willems J; Ahmed F; Vincer F; Hill R
Confl Health; 2021 Mar; 15(1):18. PubMed ID: 33789715
[TBL] [Abstract][Full Text] [Related]
24. Final report of the Conference on the eradicability of Onchocerciasis.
Dadzie Y; Neira M; Hopkins D
Filaria J; 2003 Feb; 2(1):2. PubMed ID: 12605722
[TBL] [Abstract][Full Text] [Related]
25. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
26. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
27. Genome-based tools for onchocerciasis elimination: utility of the mitochondrial genome for delineating Onchocerca volvulus transmission zones.
Crawford KE; Hedtke SM; Doyle SR; Kuesel AC; Armoo S; Osei-Atweneboana MY; Grant WN
Int J Parasitol; 2024 Mar; 54(3-4):171-183. PubMed ID: 37993016
[TBL] [Abstract][Full Text] [Related]
28. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
29. Taking the strain out of onchocerciasis? A reanalysis of blindness and transmission data does not support the existence of a savannah blinding strain of onchocerciasis in West Africa.
Cheke RA; Little KE; Young S; Walker M; Basáñez MG
Adv Parasitol; 2021; 112():1-50. PubMed ID: 34024357
[TBL] [Abstract][Full Text] [Related]
30. "Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".
Lakwo T; Ukety T; Bakajika D; Tukahebwa E; Awaca P; Amazigo U
Global Health; 2018 Feb; 14(1):16. PubMed ID: 29409509
[TBL] [Abstract][Full Text] [Related]
31. Population biology of human onchocerciasis.
Basáñez MG; Boussinesq M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
[TBL] [Abstract][Full Text] [Related]
32. Onchocerciasis (river blindness) - more than a century of research and control.
Brattig NW; Cheke RA; Garms R
Acta Trop; 2021 Jun; 218():105677. PubMed ID: 32857984
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
34. The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
Richards FO; Eigege A; Umaru J; Kahansim B; Adelamo S; Kadimbo J; Danboyi J; Mafuyai H; Saka Y; Noland GS; Anyaike C; Igbe M; Rakers L; Griswold E; Unnasch TR; Nwoke BEB; Miri E
Am J Trop Med Hyg; 2020 Mar; 102(3):582-592. PubMed ID: 32043442
[TBL] [Abstract][Full Text] [Related]
35. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
[TBL] [Abstract][Full Text] [Related]
36. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
37. Situation analysis of onchocerciasis in Cameroon: a protocol for systematic review of epidemiological studies and impact of disease control interventions.
Nana-Djeunga HC; Domche A; Niamsi-Emalio Y; Moungui HC; Walker M; Basáñez MG; Kamgno J
Syst Rev; 2020 Feb; 9(1):27. PubMed ID: 32046791
[TBL] [Abstract][Full Text] [Related]
38. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
39. The Onchocerciasis Elimination Program for the Americas (OEPA).
Sauerbrey M
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
[TBL] [Abstract][Full Text] [Related]
40. Refocusing vector assessment towards the elimination of onchocerciasis from Africa: a review of the current status in selected countries.
Boakye D; Tallant J; Adjami A; Moussa S; Tekle A; Robalo M; Rebollo M; Mwinza P; Sitima L; Cantey P; Mackenzie C
Int Health; 2018 Mar; 10(suppl_1):i27-i32. PubMed ID: 29471346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
